CREBBP and Rubinstein-Taybi syndrome: The finding that transgenic mice with brains producing a dominant negative variant of CBP and blood cell-lines from RSTS patients with mutations in the CBP lysine acetyltransferase domain show reduced CRE-dependent transcription lends credence to this notion.